Watch USNA. Know when insiders buy.
One email the day a filing lands. Free.
USNA
USANA HEALTH SCIENCES INC
14.82
+0.45 +3.13%
USD · close Oct 2
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
93
PASS · shorts 93
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $273.8MP/E —DIV YIELD —FCF YIELD 5.82%REV TTM $913.4M +1.6%NET INCOME −$22.2M −165.0%NET CASH —52W 12.86 – 27.16SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2027 · Jul 4 | $223.3M | −5.3% | 78.3% | −$20M | −$21.4M | −321.5% | -1.16 | $23.3M | $3.2M | $20.2M | Aug 13 |
| Q1 2027 · Apr 4 | $250.2M | +0.3% | 76.2% | $13.9M | $7.5M | −20.1% | 0.41 | $9.8M | $2.6M | $7.1M | May 12 |
| Q4 2026 · Jan 3derived | $226.2M | +5.9% | 78.2% | $3.8M | −$1.8M | −139.9% | -0.09 | −$3.4M | $2.8M | −$6.2M | Mar 16 |
| Q3 2026 · Sep 27 | $213.7M | +6.7% | 77.2% | $1.2M | −$6.5M | −161.5% | -0.36 | −$2M | $3.2M | −$5.2M | Nov 5 |
| Q2 2026 · Jun 28 | $235.8M | +10.8% | 78.7% | $16.7M | $9.7M | −7.4% | 0.52 | $12.2M | $5M | $7.2M | Aug 13 |
| Q1 2026 · Mar 29 | $249.5M | +9.5% | 79.0% | $15.7M | $9.4M | −43.1% | 0.49 | $15.5M | $2.8M | $12.7M | May 12 |
| Q4 2025 · Dec 28derived | $213.6M | −3.4% | 82.0% | $8.2M | $4.5M | −73.4% | 0.23 | $5.8M | $1.8M | $4M | Mar 16 |
| Q3 2025 · Sep 28 | $200.2M | −6.2% | 80.4% | $15.6M | $10.6M | −6.5% | 0.56 | $29.5M | $2.4M | $27.1M | Nov 5 |
| Q2 2025 · Jun 29 | $212.9M | — | 81.1% | $17.8M | $10.4M | — | 0.54 | $8M | $2.7M | $5.3M | Aug 5 |
| Q1 2025 · Mar 30 | $227.8M | — | 81.1% | $24.7M | $16.5M | — | 0.86 | $17.7M | $3.2M | $14.5M | May 6 |
| Q4 2024 · Dec 30derived | $221.1M | — | 80.9% | $24.2M | $16.8M | — | 0.87 | $26M | $7.3M | $18.7M | Mar 16 |
| Q3 2024 · Sep 30 | $213.4M | — | 80.1% | $17.6M | $11.3M | — | 0.59 | $22.2M | $1.5M | $20.8M | Nov 5 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2026 · to Jan 3 | $925.3M | 78.3% | $37.4M | $10.8M | 1.2% | 0.58 | $22.3M | $13.8M | $8.5M | $27.5M | — |
| FY2025 · to Dec 28 | $854.5M | 81.1% | $66.3M | $42M | 4.9% | 2.19 | $61M | $10.1M | $50.9M | $9.4M | — |
| FY2024 · to Dec 30 | $921M | 80.8% | $93.1M | $63.8M | 6.9% | 3.30 | $70.6M | $14.5M | $56.1M | $11.6M | — |
| FY2023 · to Dec 31 | $998.6M | 80.6% | $107.6M | $69.3M | 6.9% | 3.59 | $103.9M | $10.4M | $93.5M | $25.4M | — |
| FY2022 · to Jan 1 | $1.2B | 81.6% | $170.2M | $116.5M | 9.8% | 5.73 | $121.2M | $12.8M | $108.5M | $177.8M | — |
| FY2021 · to Jan 2 | $1.1B | 81.6% | $176.5M | $124.7M | 11.0% | 5.86 | $160.4M | $15.1M | $145.3M | $57M | — |
Every number comes from USANA HEALTH SCIENCES INC's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.